Medicare IHC Claims With Melanoma Dxs Increased, Study Finds Medicare IHC Claims With Melanoma Dxs Increased, Study Finds

With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Dermatology Source Type: news